• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

充血性心力衰竭时血浆神经肽Y水平升高。

Elevation of plasma neuropeptide Y levels in congestive heart failure.

作者信息

Maisel A S, Scott N A, Motulsky H J, Michel M C, Boublik J H, Rivier J E, Ziegler M, Allen R S, Brown M R

机构信息

Department of Medicine, University of California, San Diego.

出版信息

Am J Med. 1989 Jan;86(1):43-8. doi: 10.1016/0002-9343(89)90228-3.

DOI:10.1016/0002-9343(89)90228-3
PMID:2910096
Abstract

PURPOSE

Our objectives were to assess whether plasma neuropeptide Y (NPY) levels are elevated in patients with congestive heart failure (CHF) and whether or not NPY levels can serve as a reliable indicator of sympathetic activity in CHF.

PATIENTS AND METHODS

Plasma levels of the sympathetic neurotransmitters norepinephrine and epinephrine and of the sympathetic co-transmitter NPY were measured in 17 patients with CHF and 14 healthy control subjects at rest and after maximal exercise.

RESULTS

Under resting conditions, plasma NPY and norepinephrine levels were elevated in patients with CHF compared with control subjects (551 +/- 48 pg/ml versus 311 +/- 22 pg/ml, p less than or equal to 0.001 for NPY, and 306 +/- 73 pg/ml versus 124 +/- 22 pg/ml, p less than or equal to 0.02 for norepinephrine). Plasma NPY correlated better with plasma norepinephrine than with epinephrine, indicating its origin from sympathetic nerve terminals. Acute stimulation of sympathetic activity by dynamic exercise increased plasma norepinephrine levels in control subjects and patients with CHF, but did not significantly alter the mean plasma NPY value in the latter group.

CONCLUSION

NPY may play a role in the pathophysiology of CHF.

摘要

目的

我们的目标是评估充血性心力衰竭(CHF)患者血浆神经肽Y(NPY)水平是否升高,以及NPY水平能否作为CHF交感神经活动的可靠指标。

患者与方法

在静息状态和最大运动后,测量了17例CHF患者和14名健康对照者血浆中交感神经递质去甲肾上腺素和肾上腺素以及交感神经共同递质NPY的水平。

结果

在静息状态下,CHF患者血浆NPY和去甲肾上腺素水平高于对照者(NPY:551±48 pg/ml对311±22 pg/ml,p≤0.001;去甲肾上腺素:306±73 pg/ml对124±22 pg/ml,p≤0.02)。血浆NPY与血浆去甲肾上腺素的相关性优于与肾上腺素的相关性,表明其来源于交感神经末梢。动态运动对交感神经活动的急性刺激使对照者和CHF患者血浆去甲肾上腺素水平升高,但未显著改变CHF患者组的平均血浆NPY值。

结论

NPY可能在CHF的病理生理学中起作用。

相似文献

1
Elevation of plasma neuropeptide Y levels in congestive heart failure.充血性心力衰竭时血浆神经肽Y水平升高。
Am J Med. 1989 Jan;86(1):43-8. doi: 10.1016/0002-9343(89)90228-3.
2
Plasma immunoreactive neuropeptide Y in congestive heart failure at rest and during exercise.充血性心力衰竭患者静息及运动时血浆免疫反应性神经肽Y水平
Scand J Clin Lab Invest. 1993 Oct;53(6):569-76.
3
Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure.充血性心力衰竭患者血浆去甲肾上腺素和肾上腺素对动态运动的反应。
Am J Cardiol. 1982 Apr 1;49(5):1152-6. doi: 10.1016/0002-9149(82)90039-x.
4
Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure.充血性心力衰竭患者血浆神经肽Y和去甲肾上腺素对动态运动及雷米普利治疗的反应。
Clin Physiol. 1994 Mar;14(2):123-34. doi: 10.1111/j.1475-097x.1994.tb00498.x.
5
Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.人体交感神经激活过程中血浆神经肽Y浓度的升高。
J Auton Nerv Syst. 1986 Oct;17(2):143-9. doi: 10.1016/0165-1838(86)90089-5.
6
Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.充血性心力衰竭中神经肽Y、儿茶酚胺与血流动力学之间的关系。
Eur Heart J. 1992 Sep;13(9):1233-8. doi: 10.1093/oxfordjournals.eurheartj.a060342.
7
[Evaluation of plasma neuropeptide Y levels in patients with congestive heart failure].[充血性心力衰竭患者血浆神经肽Y水平的评估]
Zhonghua Nei Ke Za Zhi. 1994 Oct;33(10):687-9.
8
Responses of plasma norepinephrine and renin-angiotensin-aldosterone system to dynamic exercise in patients with congestive heart failure.充血性心力衰竭患者血浆去甲肾上腺素和肾素-血管紧张素-醛固酮系统对动态运动的反应。
J Card Fail. 1996 Jun;2(2):103-10. doi: 10.1016/s1071-9164(96)80028-5.
9
Neuropeptide Y, noradrenaline and invasive haemodynamic data in mild to moderate chronic congestive heart failure.轻至中度慢性充血性心力衰竭患者的神经肽Y、去甲肾上腺素及有创血流动力学数据
Clin Physiol. 1993 Jul;13(4):409-18. doi: 10.1111/j.1475-097x.1993.tb00340.x.
10
Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.人体不同程度交感神经激活过程中的血浆神经肽Y样免疫反应性和儿茶酚胺
Clin Physiol. 1986 Dec;6(6):561-78. doi: 10.1111/j.1475-097x.1986.tb00789.x.

引用本文的文献

1
Stellate Ganglia: A Key Therapeutic Target for Malignant Ventricular Arrhythmia in Heart Disease.星状神经节:心脏病恶性室性心律失常的关键治疗靶点。
Circ Res. 2025 Apr 25;136(9):1049-1069. doi: 10.1161/CIRCRESAHA.124.325384. Epub 2025 Apr 24.
2
Circulating neuropeptide Y dynamics and performance during exercise in heart failure patients with contemporary medical and device therapy.当代药物及器械治疗的心力衰竭患者运动期间循环神经肽Y的动态变化及运动表现
Exp Physiol. 2025 Mar;110(3):401-409. doi: 10.1113/EP092325. Epub 2025 Jan 24.
3
Bayliss Starling Prize Lecture 2023: Neuropeptide-Y being 'unsympathetic' to the broken hearted.
2023年贝利斯·斯塔林奖讲座:神经肽Y对心碎之人“无动于衷”
J Physiol. 2025 Mar;603(7):1841-1864. doi: 10.1113/JP285370. Epub 2024 Jun 7.
4
Autonomic control of ventricular function in health and disease: current state of the art.自主神经对心室功能在健康和疾病中的控制:当前的最新技术。
Clin Auton Res. 2023 Aug;33(4):491-517. doi: 10.1007/s10286-023-00948-8. Epub 2023 May 11.
5
Neuropeptide Y and Metabolism Syndrome: An Update on Perspectives of Clinical Therapeutic Intervention Strategies.神经肽Y与代谢综合征:临床治疗干预策略观点的最新进展
Front Cell Dev Biol. 2021 Jul 9;9:695623. doi: 10.3389/fcell.2021.695623. eCollection 2021.
6
Neurohumoral, cardiac and inflammatory markers in the evaluation of heart failure severity and progression.神经体液、心脏和炎症标志物在评估心力衰竭严重程度及进展中的作用
J Geriatr Cardiol. 2021 Jan 28;18(1):47-66. doi: 10.11909/j.issn.1671-5411.2021.01.007.
7
Cardiac and Vascular α-Adrenoceptors in Congestive Heart Failure: A Systematic Review.充血性心力衰竭中心血管α-肾上腺素能受体:系统评价。
Cells. 2020 Nov 4;9(11):2412. doi: 10.3390/cells9112412.
8
Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers.交感神经系统激活与心力衰竭:基于新型生物标志物的证据现状及病理生理学
World J Cardiol. 2020 Aug 26;12(8):373-408. doi: 10.4330/wjc.v12.i8.373.
9
Cardiac sympathetic activation circumvents high-dose beta blocker therapy in part through release of neuropeptide Y.心脏交感神经激活部分绕过了大剂量β受体阻滞剂治疗,其机制之一是通过神经肽 Y 的释放。
JCI Insight. 2020 Jun 4;5(11):135519. doi: 10.1172/jci.insight.135519.
10
Neuroimmune crosstalk in the pathophysiology of hypertension.神经免疫相互作用与高血压的病理生理学。
Nat Rev Cardiol. 2019 Aug;16(8):476-490. doi: 10.1038/s41569-019-0178-1.